Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Oct 17:2018:8606430.
doi: 10.1155/2018/8606430. eCollection 2018.

Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass

Affiliations
Case Reports

Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass

Sebastiano Cicco et al. Case Rep Hematol. .

Abstract

Primary systemic amyloidosis is not easily diagnosed. The immunoglobulin deposits are usually localized in the kidney, heart, and liver. We describe an unusual case of a patient suffering from a pericardial amyloidoma with internal calcifications and air bubbles that compressed the right ventricle and shifted the heart to the left. Since the patient was in shock, urgent pericardiotomy was performed. This site showed PET uptake. A monoclonal component was present. On these findings, differential diagnoses included multiple myeloma and atypical pericardial tuberculosis, whereas a periumbilical fat tissue biopsy demonstrated amyloidosis. A previous Salmonella species infection had most likely stimulated the production of amyloid. The patient received bortezomib/dexamethasone treatment and achieved a good response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest CT scan. The mass is compressing the right ventricle and shifting the heart. Pleural effusion is present, with compression of the left lung.
Figure 2
Figure 2
Serum protein electrophoresis before (a) and after (b) therapy. After therapy, there was a reduction of the monoclonal component (1).
Figure 3
Figure 3
Amyloid deposition in periumbilical fat ((a)-Congo red) with apple-green birefringence (b) at polarized microscope analysis.

References

    1. Merlini G., Dammacco F. Amiloidosi e manifestazioni cliniche correlate. Internal and Emergency Medicine. 2006;1(S1–3):83S–109S.
    1. Merlini G., Seldin D. C., Gertz M. A. Amyloidosis: pathogenesis and new therapeutic options. Journal of Clinical Oncology. 2011;29(4):1924–1933. doi: 10.1200/jco.2010.32.2271. - DOI - PMC - PubMed
    1. Cohen A. D., Comenzo R. L. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematology. 2010;2010(1):287–294. doi: 10.1182/asheducation-2010.1.287. - DOI - PubMed
    1. Rosenzweig M., Landau H. Light chain (AL) amyloidosis: update on diagnosis and management. Journal of Hematology and Oncology. 2011;4(1):p. 47. doi: 10.1186/1756-8722-4-47. - DOI - PMC - PubMed
    1. Agis H. News in AL amyloidosis ASH 2016: a rapidly evolving field of investigation. Memo-Magazine of European Medical Oncology. 2017;10(2):66–71. doi: 10.1007/s12254-017-0332-6. - DOI - PMC - PubMed

Publication types

LinkOut - more resources